相关实验视频
Updated: Jan 8, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
875
在治疗肥胖药物治疗期间饮食行为的变化
Ming Chuen Chong1, Tak Ying Louise Ko1, Philippus L le Roux1
1Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
Clinical obesity
|December 20, 2025
概括
药理肥胖治疗有效地减少食欲和食物的渴望. 患者经历减肥和维护作为一个频谱,部分控制是关键的长期行为.
科学领域:
- 肥胖研究的研究.
- 行为科学是一种行为科学.
- 药理干预措施 药理干预措施
背景情况:
- 肥胖是一种复杂的,由多种因素影响的慢性疾病.
- 药理疗法有助于减肥,但对饮食行为的长期影响尚不清楚.
研究的目的:
- 探索患者在动态和稳定阶段的减肥药物和饮食行为方面的经验.
- 了解从减肥过渡到维持体重的过程.
主要方法:
- 使用31个半结构面试进行的定性研究.
- 对面试的主题分析,重点关注饥饿,腹,食物想法,份量大小和食感.
主要成果:
- 动态阶段:深刻的食欲抑制,早期的腹,减少食物噪音,更小的部分.
- 部分控制是跨阶段持续的行为变化.
- 长期目标从减肥转变为维持体重;在稳定阶段出现药物疗效问题.
结论:
- 体重管理是一个频谱,而不是二分法.
- 以患者为中心的见解可以为临床实践,政策和未来关于肥胖药物治疗的研究提供信息.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
221
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
Binge Eating Disorders
402
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
402
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Bulimia Nervosa
641
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
641
Drug Dosing: Obese Patients
198
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
198
Regulation of Food Intake
2.2K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.2K

